GVS
870976
Hangzhou CNCR-IT
300250
Shanghai Newtouch Software
688590
Ucap Cloud Information Technology Co.,Ltd
688228
Yangtze Optical Electronic
688143
CN Stock MarketDetailed Quotes
002004 Huapont Life Sciences
- 3.84
- +0.05+1.32%
Market Closed Jan 24 15:00 CST
7.60BMarket Cap30.48P/E (TTM)
3.84High3.76Low265.60KlotVolume3.80Open3.79Pre Close101.10MTurnover1.41%Turnover Ratio25.10P/E (Static)1.98BShares5.2352wk High0.75P/B7.23BFloat Cap3.5652wk Low4.17Limit Up1.88BShs Float18.17Historical High3.41Limit Down2.11%Amplitude-1.63Historical Low0.22Dividend TTM3.81Avg Price109.39KlotAsk5.73%Div YieldTTM100Lot Size151.41KlotBid
Huapont Life Sciences News
Huabang Health: 2024 Annual Results Forecast
Huabang Health: Announcement on the extension of the controlling shareholder\'s partial share pledge
Huabang Health: Announcement of Resolutions of the 2024 First Extraordinary General Meeting of Shareholders
Huabang Health: Legal Opinion of the 2024 First Extraordinary General Meeting of Shareholders
Huabang Health: Comparative table of amendments to the company\'s articles of association
Huabang Health: Announcement of Resolutions of the 14th Meeting of the Eighth Board of Supervisors
Huabang Health: Feasibility analysis report on the development of forward foreign exchange settlement services and RMB to foreign exchange option portfolios in 2025
Huabang Health: Supervisory Board Rules of Procedure (December 2024)
Huabang Health: Announcement on the expected launch of forward foreign exchange settlement services and RMB to foreign exchange option combinations in 2025
Huabang Health: Shareholders\' Meeting Rules of Procedure (December 2024)
Huabang Health: Notice on Convening the First Extraordinary General Meeting of Shareholders in 2024
Huabang Health: Administrative Measures on the Use of Funds Raised (December 2024)
Huabang Health: Announcement on the Company and its subsidiaries applying for credit lines and guarantee matters from banks and other financial institutions in 2025
Huabang Health: Announcement of Resolutions of the 21st Meeting of the Eighth Board of Directors
Huabang Health: Board of Directors Rules of Procedure (December 2024)
Huabang Health: Articles of Association (December 2024)
Huabang Health: Independent opinions of independent directors on matters related to the 21st meeting of the 8th board of directors
Huabang Health: Announcement on increasing the forecast for daily related transactions in 2024 and the expected daily related transactions for 2025
Huabang Health: Announcement on the non-public issuance of exchangeable corporate bonds
Huabang Health: Announcement on the Wholly-owned Subsidiary Obtaining the “Drug Registration Certificate”